Lionsgate (LION) director sells 113,367 shares; 20,066 RSUs vest Nov 29

Rhea-AI Filing Summary

Insider transaction by Lionsgate director Yvette Ostolaza: The Form 4 reports a sale of 113,367 common shares on 09/15/2025 by a director of Lionsgate Studios Corp. The filing notes that the total amount reported includes 20,066 restricted share units (RSUs) that the issuer granted and that are payable upon vesting. Those RSUs are scheduled to vest on November 29, 2025. The disclosure indicates the transaction was reported by a single reporting person and executed by power of attorney on behalf of Ms. Ostolaza.

Positive

• Disclosure transparency: The reporting complies with Section 16 reporting by identifying the transaction and the RSUs.
• Ongoing alignment: 20,066 restricted share units remain scheduled to vest on November 29, 2025, maintaining some equity alignment with shareholders.

Negative

• Large disposition: A sale of 113,367 common shares by a director could be viewed negatively by some investors absent an explanation.

Insights

Financial Analyst

TL;DR: A director sold 113,367 shares; 20,066 RSUs remain scheduled to vest, producing a neutral-to-cautious signal without further context.

The reported disposal of 113,367 common shares is a clear, quantifiable change in insider holdings. Without additional context—such as pre-transaction holdings, price, or a company plan—this single filing does not by itself indicate a material change to the company's fundamentals. The mention of 20,066 RSUs payable on vesting shows continued executive alignment with equity compensation, which partially offsets concerns about the sale. Impact rating is neutral due to limited information.

Corporate Governance Expert

TL;DR: Director-level disposition disclosed; governance transparency is intact but the sale size warrants monitoring by investors.

The Form 4 provides required disclosure of a director's disposition and identifies the existence and vesting date of restricted share units. This satisfies statutory transparency obligations. From a governance perspective, the scheduled vesting of 20,066 RSUs suggests ongoing linkage between the director and shareholder outcomes. However, the substantial number of shares disposed may prompt questions about the reasons for the sale; the filing contains no explanation, limiting governance conclusions.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Ostolaza Yvette

Role Director

Type	Security	Shares	Price	Value
holding	Common Shares	--	--	--

Holdings After Transaction: Common Shares — 113,367 shares (Direct)

Footnotes (1)

1. F1. Amount includes 20,066 restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer, that are scheduled to vest on November 29, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Lionsgate director Yvette Ostolaza report on Form 4 (LION)?

The Form 4 reports a disposition of 113,367 common shares by director Yvette Ostolaza, with the transaction dated 09/15/2025.

Does the Form 4 disclose any restricted share units (RSUs) for Yvette Ostolaza?

Yes. The filing states the amount reported includes 20,066 restricted share units that are payable upon vesting, scheduled to vest on November 29, 2025.

Was the Form 4 filed by multiple reporting persons for this transaction?

No. The document indicates the form was filed by one reporting person.

Was a power of attorney used in signing the Form 4 for Yvette Ostolaza?

Yes. The signature block indicates the form was submitted by Adrian Kuzycz by Power of Attorney on behalf of Yvette Ostolaza.

Does the filing explain the reason for the share disposition?

No. The filing does not provide any explanation for the disposition beyond the transaction and the RSU vesting detail.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/15/2025 - 04:31 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ostolaza Yvette

(Last) (First) (Middle)

LIONSGATE

2700 COLORADO AVENUE

(Street)

SANTA MONICA CA 90404

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lionsgate Studios Corp. [ LION ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares								113,367(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Amount includes 20,066 restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer, that are scheduled to vest on November 29, 2025.

Remarks:

	Yvette Ostolaza (By Adrian Kuzycz by Power of Attorney)	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.